Teikoku Pharma

Teikoku Pharma is a global pharmaceutical company that develops life-changing therapies through advanced science and technical ingenuity. The company focuses on creating topical transdermal, oral, and other therapies in areas such as non-opioid pain management, CNS disorders, and dermatology. They aim to improve patient lives by exploring opportunities to develop drugs independently and collaboratively with like-minded partners.

The company is located at 1718 Ringwood Ave in San Jose, California, with a main phone number of (408) 501-1800 and a fax of (408) 501-1900. They also have a presence in Milpitas, California, and serve markets including the US, UK, and Canada. Visitors can reach them via their website teikokuusa.com or through their social profiles on Facebook and LinkedIn.

Reviewers consistently praise Teikoku Pharma for the excellent quality of their products and outstanding customer service. Many customers highlight the effectiveness of the products in managing their health and improving their lives. The range of products offered is frequently described as fantastic, with customers noting that the company goes the extra mile to ensure satisfaction.

The company offers Lidoderm® (Lidocaine 5% Patch) in the US and Versatis® in the EU, which are used for post-herpetic neuralgia. They also have TPU-006, a 4-day Dexmedetomidine patch for post-operative pain management, and TK-254Rx in their pipeline. Additionally, they provide Docetaxel Alcohol-free Injection for various cancer treatments.

Teikoku Pharma has received FDA Fast Track Designation for TPU-006, a novel 4-day Dexmedetomidine transdermal system for post-operative pain management. The company also announced positive topline results from Phase 2 clinical trials of TPU-006 in Abdominoplasty Surgery and Bunionectomy Surgery. These developments highlight their focus on innovative pain management solutions.

The company uses a Hydrohesive® Matrix technology for their transdermal delivery systems. They also have a dedicated research and development team that focuses on dosage form development and comprehensive manufacturing capabilities. This expertise allows them to create formulations and delivery mechanisms that bring first-in-class therapies to life.

Teikoku Pharma targets patients suffering from non-opioid pain management needs, CNS disorders, and dermatological conditions. Their products are designed to help millions of patients worldwide, with Lidoderm® specifically noted for assisting those with post-herpetic neuralgia. The company also serves healthcare professionals and partners looking for innovative pharmaceutical solutions.

The company's website states that they take an opportunistic approach to their programs, both independently and collaboratively with like-minded partners. This strategy allows them to explore a variety of opportunities to develop drugs that improve patient lives. They also offer distribution and licensing opportunities for interested parties.

Teikoku Pharma has been operating since at least 2022, as evidenced by their reviews and news articles. They have a growing portfolio of life-changing drug therapies and are actively expanding their reach. The company is part of the key non-postoperative pain management companies in the market, alongside Gensco Pharma and Scilex Holdi.

The company's pipeline includes TPU-006, TK-254Rx, and other investigational non-opioid analgesics. They also have a focus on developing drugs that improve patient lives through advanced science and technical ingenuity. Their pipeline reflects a commitment to innovation in pain management and other therapeutic areas.

Teikoku Pharma is known for its pioneering transdermal technology, which provides pain relief after a shingles infection for up to three days. The company also develops investigational non-opioid analgesics designed to deliver dexmedetomidine for four days or longer post-surgery. This technology is a key differentiator in their product offerings.

The company's website mentions that they are a global pharmaceutical company with a focus on developing topical transdermal, oral, and other therapies. They also have a strong presence in the hospital and health care industry, as indicated by their Trustburn listing. Their global reach is supported by their international product approvals and partnerships.

The company's website includes a privacy policy and a contact form for inquiries about products, services, or general information. They also have a news section that updates visitors on the latest developments, such as clinical trial results and regulatory approvals. This ensures transparency and keeps stakeholders informed.

The official website of Teikoku Pharma is teikokuusa.com.

On Trustburn, Teikoku Pharma has a rating of 4 out of 5 based on 12 reviews.